Search Results - "Claassens, M. M."

Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys by Claassens, M M, van Schalkwyk, C, Floyd, S, Ayles, H, Beyers, N

“…High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to…”
Get full text

Breath analysis as a potential diagnostic tool for tuberculosis by Kolk, A. H. J., van Berkel, J. J. B. N., Claassens, M. M., Walters, E., Kuijper, S., Dallinga, J. W., van Schooten, F. J.

“…SETTING: Cape Town, South Africa.OBJECTIVES: We investigated the potential of breath analysis by gas chromatography-mass spectrometry (GC-MS) to discriminate…”
Get full text

Tuberculosis in healthcare workers and infection control measures at primary healthcare facilities in South Africa by Claassens, Mareli M, van Schalkwyk, Cari, du Toit, Elizabeth, Roest, Eline, Lombard, Carl J, Enarson, Donald A, Beyers, Nulda, Borgdorff, Martien W

“…Challenges exist regarding TB infection control and TB in hospital-based healthcare workers in South Africa. However, few studies report on TB in non-hospital…”
Get full text

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI by Claassens, Daniel M.F, Vos, Gerrit J.A, Bergmeijer, Thomas O, Hermanides, Renicus S, van ’t Hof, Arnoud W.J, van der Harst, Pim, Barbato, Emanuele, Morisco, Carmine, Tjon Joe Gin, Richard M, Asselbergs, Folkert W, Mosterd, Arend, Herrman, Jean-Paul R, Dewilde, Willem J.M, Janssen, Paul W.A, Kelder, Johannes C, Postma, Maarten J, de Boer, Anthonius, Boersma, Cornelis, Deneer, Vera H.M, ten Berg, Jurriën M

“…Patients undergoing primary PCI were randomly assigned to either a genotype-guided strategy for selecting a P2Y 12 inhibitor or to standard treatment with…”
Get full text

Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa by Kweza, P. F., Van Schalkwyk, C., Abraham, N., Uys, M., Claassens, M. M., Medina-Marino, A.

“…SETTING: The present study was conducted at 20 randomly selected primary health clinics across Buffalo City Metropolitan Health District, a high TB burden…”
Get full text

Mortality during tuberculosis treatment in South Africa using an 8-year analysis of the national tuberculosis treatment register by Osman, Muhammad, van Schalkwyk, Cari, Naidoo, Pren, Seddon, James A., Dunbar, Rory, Dlamini, Sicelo S., Welte, Alex, Hesseling, Anneke C., Claassens, Mareli M.

“…In 2011, the South African HIV treatment eligibility criteria were expanded to allow all tuberculosis (TB) patients lifelong ART. The impact of this change on…”
Get full text

Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey by Gunasekera, K., Cohen, T., Gao, W., Ayles, H., Godfrey-Faussett, P., Claassens, M.

“…BACKGROUND: Despite multiple tuberculosis (TB) prevalence surveys reporting a relatively high frequency of bacteriologically confirmed, active TB among…”
Get full text

Enhanced active case finding of drug-resistant tuberculosis in Namibia: a protocol for the hotspots, hospitals, and households (H3TB) study by Shavuka, Olga, Iipumbu, Etuhole, Boois, Lorraine, Günther, Gunar, Hoddinott, Graeme, Lin, Hsien-Ho, Nepolo, Emmanuel, Niemann, Stefan, Ruswa, Nunurai, Seddon, James, Claassens, Mareli M

“…IntroductionNamibia is a high tuberculosis (TB)-burden country with an estimated incidence of 460/100 000 (around 12 000 cases) per year. Approximately 4.5% of…”
Get full text

Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia by Claassens, M, Dreyer, V, Nepolo, E, Mokomele, Q, van Rooyen, G, Ruswa, N, Günther, G, Niemann, S

“…Namibia is among 30 countries with a high burden of tuberculosis (TB), with an estimated incidence of 460 per 100,000 population and around 800 new…”
Get full text

Tuberculosis cases missed in primary health care facilities: should we redefine case finding? by Claassens, M. M., Jacobs, E., Cyster, E., Jennings, K., James, A., Dunbar, R., Enarson, D. A., Borgdorff, M. W., Beyers, N.

“…SETTING: This study was conducted in Cape Town in two primary health care facilities in a sub-district with a high prevalence of bacteriologically confirmed…”
Get full text

Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR) by Bond, V., Floyd, S., Fenty, J., Schaap, A., Godfrey-Faussett, P., Claassens, M., Shanaube, K., Ayles, H., Hargreaves, J. R.

“…SETTING: Zambian and South African TB and HIV Reduction (ZAMSTAR) cluster-randomised trial (CRT) communities, 2006-2009.OBJECTIVES: To develop TB stigma items,…”
Get full text

Tuberculosis patients in primary care do not start treatment. What role do health system delays play? by Claassens, M. M., du Toit, E., Dunbar, R., Lombard, C., Enarson, D. A., Beyers, N., Borgdorff, M. W.

“…SETTING: Primary health care facilities in five provinces of South Africa.OBJECTIVE: To investigate the association between the proportion of sputum results…”
Get full text

A systematic review of prediction models for prevalent pulmonary tuberculosis in adults by Van Wyk, S. S., Lin, H. H., Claassens, M. M.

“…A systematic review was conducted to describe the quality and characteristics of prediction models for prevalent pulmonary tuberculosis (PTB) in adults at…”
Get full text

Scanty smears associated with initial loss to follow-up in South African tuberculosis patients by Claassens, M. M., Dunbar, R., Yang, B., Lombard, C. J.

“…BACKGROUND: Smear-positive patients should be started on anti-tuberculosis treatment promptly. However, studies show that up to 38% of diagnosed patients are…”
Get full text

Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa by Claassens, Mareli M, van Schalkwyk, Cari, Dunbar, Rory, Ayles, Helen, Beyers, Nulda

“…To address the uncertainty of the indirectly measured tuberculosis case detection rate, we used survey data stratified by HIV status to calculate the patient…”
Get full text

Tuberculosis cure rates and the ETR.Net: investigating the quality of reporting treatment outcomes from primary healthcare facilities in Mpumalanga province, South Africa by Dreyer, A W, Mbambo, D, Machaba, M, Oliphant, C E M, Claassens, M M

“…Tuberculosis control programs rely on accurate collection of routine surveillance data to inform program decisions including resource allocation and specific…”
Get full text

A systematic review of risk factors for mortality among tuberculosis patients in South Africa by Nicholson, Tamaryn J, Hoddinott, Graeme, Seddon, James A, Claassens, Mareli M, van der Zalm, Marieke M, Lopez, Elisa, Bock, Peter, Caldwell, Judy, Da Costa, Dawood, de Vaal, Celeste, Dunbar, Rory, Du Preez, Karen, Hesseling, Anneke C, Joseph, Kay, Kriel, Ebrahim, Loveday, Marian, Marx, Florian M, Meehan, Sue-Ann, Purchase, Susan, Naidoo, Kogieleum, Naidoo, Lenny, Solomon-Da Costa, Fadelah, Sloot, Rosa, Osman, Muhammad

“…Tuberculosis (TB)-associated mortality in South Africa remains high. This review aimed to systematically assess risk factors associated with death during TB…”
Get full text

Beyond revenge? : responsible Bible reading practices in a Traumatized Land by Claassens, Juliana M.

“…In this article, I argue that revenge fantasies such as those found in the Oracles Against the Nations (OAN) in Jeremiah 45–51 underscore the necessity for…”
Get full text

Health care workers' gender bias in testing could contribute to missed tuberculosis among women in South Africa by Smith, A., Burger, R., Claassens, M., Ayles, H., Godfrey-Faussett, P., Beyers, N.

“…SETTING: Eight communities with high tuberculosis (TB) prevalence, Western Cape, South Africa.OBJECTIVE: To identify sex differences in TB health-seeking…”
Get full text

Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy by Al-Rubaish, Abdullah M, Al-Muhanna, Fahad A, Alshehri, Abdullah M, Al-Mansori, Mohammed A, Alali, Rudaynah A, Khalil, Rania M, Al Faraidy, Khalid A, Cyrus, Cyril, Sulieman, Mohammed M, Vatte, Chittibabu, Claassens, Daniel M F, Ten Berg, Jurriën M, Asselbergs, Folkert W, Al-Ali, Amein K

“…To mitigate the risk of stent thrombosis, patients treated by percutaneous coronary intervention (PCI) are administered dual anti-platelet therapy comprising…”
Get full text